Tectonic Therapeutic, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Tectonic Therapeutic, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2017 to Q2 2024.
  • Tectonic Therapeutic, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$1.25M, a 810% decline year-over-year.
  • Tectonic Therapeutic, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $1.79M, a 163% increase year-over-year.
  • Tectonic Therapeutic, Inc. annual Nonoperating Income (Expense) for 2023 was $2.34M.
  • Tectonic Therapeutic, Inc. annual Nonoperating Income (Expense) for 2022 was -$456K, a 60% decline from 2021.
  • Tectonic Therapeutic, Inc. annual Nonoperating Income (Expense) for 2021 was -$285K, a 155% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.79M -$1.25M -$1.43M -810% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $3.21M $1.13M +$870K +331% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.34M $547K +$324K +145% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $2.02M $1.36M +$1.34M +8375% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $678K $176K +$456K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $222K $263K +$678K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$456K $223K +$488K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$944K $16K +$9K +129% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$953K -$280K -$268K -2233% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$685K -$415K -$400K -2667% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$285K -$265K -$198K -296% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$87K $7K +$69K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$156K -$12K -$41K -141% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$115K -$15K -$631K -102% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $516K -$67K -$838K -109% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $1.35M -$62K -$981K -107% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $2.34M $29K -$528K -94.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $2.86M $616K +$19K +3.18% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $2.84M $771K +$116K +17.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 $2.73M $919K +$278K +43.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $2.45M $557K +$1.52M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $933K $597K +$1.05M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$118K $655K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $641K +$712K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$960K -$968K -12100% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$454K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q3 2017 -$71K Jun 24, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $8K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.